Vnitr Lek 2022, 68(7):449-453 | DOI: 10.36290/vnl.2022.094

Reactive, infectious, or post‑infectious arthritis?

Štefan Alušík
Katedra vnitřního lékařství, IPVZ Praha

The issue of reactive arthritis belongs to one of the most complex problems in rheumatology. Although the original concept of reactive arthritis as a "sterile arthritis" has already been overcome, much remains unclear. Non-uniform terminology, classification and diagnostic criteria as well as treatment guidelines leave room for different interpretations of this issue. Therefore it is difficult for non-rheumatologists (internal medicine physicians and general practitioners) to find their way around this topic. Our comprehensive report discusses the latest findings from etiology to treatment of reactive arthritis. It also addresses the aforementioned controversies from terminology to the latest list of causative pathogens, including viruses, parasites and vaccines.

Keywords: reactive arthritis, post‑infectious arthritis, new causative pathogens, diagnosis, treatment.

Accepted: October 17, 2022; Published: October 31, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Alušík Š. Reactive, infectious, or post‑infectious arthritis? Vnitr Lek. 2022;68(7):449-453. doi: 10.36290/vnl.2022.094.
Download citation

References

  1. Kuipers JG, Scharmann K, Wollenhaupt J et al. Sensitivities of PCR, MicroTrak, Chlamydia EIA, IDEIA, and PACE 2 for purified Chlamydia trachomatis elementary bodies in urine, peripheral blood, peripheral blood leukocytes, and synovial fluid. J Clin Microbiol. 1995;33(12):3186-90. Go to original source... Go to PubMed...
  2. Kuipers JG, Kohler L, Zeidler H. Reactive or infectious arthritis. Ann Rheum Dis. 1999;58:661-664. Go to original source... Go to PubMed...
  3. Braun J, Kingsley G, van der Heijde D et al. On the difficulties of establishing a consensus on the definition of and diagnostic investigations for reactive arthritis. Results and discussion of a questionnaire prepared for the 4th International Workshop on Reactive Arthritis, Berlin, Germany, July 3-6, 1999. J Rheumatol. 2000;27(9):2185-92. Go to PubMed...
  4. Bekaryssova, D., Yessirkepov, M., Zimba, O. et al. Reactive arthritis before and after the onset of the COVID-19 pandemic. Clin Rheumatol. 2022; 41(6):1641-1652. Go to original source... Go to PubMed...
  5. Ferreira A, Monteiro M, Vita P et al. al. Post‑infectious arthritis and reactive arthritis. Infection and Autoimmunity.(Second Edit.). Elsevier 2015; 807- 828. Available from: www:https://doi.org/10.1016/B978-0-444-63269-2.00050-7 Go to original source...
  6. Morris D, Inman RD. Reactive arthritis: developments and challenges in diagnosis and treatment. Curr Rheumatol Rep. 2012;14(5):390-4. Go to original source... Go to PubMed...
  7. Bojović J, Strelić N, Pavlica L. Reiter's syndrome--disease of young men-- analysis of 312 patients. Med Pregl. 2014;67(7-8):222-30 Go to original source... Go to PubMed...
  8. Hanova P, Pavelka K, Holcatova I et al. Incidence and prevalence of psoriatic arthritis, ankylosing spondylitis, and reactive arthritis in the first descriptive population‑based study in the Czech Republic. Scand J Rheumatol. 2010;39(4):310-7. Go to original source... Go to PubMed...
  9. Zeidler H, Hudson AP. Reactive Arthritis Update: Spotlight on New and Rare Infectious Agents Implicated as Pathogens. Curr Rheumatol Rep. 2021;23(7):53 Go to original source... Go to PubMed...
  10. Jubber A, Moorthy A. Reactive arthritis: a clinical review. J R Coll Physicians Edinb. 2021;51(3):288-297. Go to original source... Go to PubMed...
  11. Kobayashi S, Taniguchi Y, Kida I et al. SARS‑CoV2-triggered acute arthritis: Viral arthritis rather than reactive arthritis. J Med Virol. 2021;93(12):6458-6459. Go to original source... Go to PubMed...
  12. Facciolà A, Visalli G, Laganà A et al. An Overview of Vaccine Adjuvants:Current Evidence and Future Perspectives. Vaccines 2022;10, 819. Available from: www: https://doi.org/10.3390/vaccines10050819. Go to original source... Go to PubMed...
  13. Valesová M, Trnavský K, Hulínská D et al. Detection of Borrelia in the synovial tissue from a patient with Lyme borreliosis by electron microscopy. J Rheumatol. 1989;16(11):1502-5. Go to PubMed...
  14. Sharip A, Kunz J. Understanding the Pathogenesis of Spondyloarthritis. Biomolecules. 2020;10(10):1461. Available from: www: https://doi.org/10.3390/biom10101461. Go to original source... Go to PubMed...
  15. Brockett MR, Liechti GW. Persistence Alters the Interaction between Chlamydia trachomatis and Its Host Cell. Infect Immun. 2021;89(8):e0068520. Available from: www: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281235/. Go to original source... Go to PubMed...
  16. Manasson J, Shen N, Ferrer HRG et al. Gut microbiota perturbations in reactive arthritis and post‑infectious spondyloarthritis. Arthritis Rheumatol. 2018;70(2):242-54.
  17. Shetty S, Kouskouti C, Schoen U et al. Diagnosis of Chlamydia trachomatis genital infections in the era of genomic medicine. Braz J Microbiol. 2021;52(3):1327-1339. Go to original source... Go to PubMed...
  18. Kebbi‑Beghdadi C, Aeby S, Baud D, Greub G. Evaluation of a Multiplex Real‑Time PCR Assay for Detecting Chlamydia trachomatis in Vaginal Samples. Diagnostics (Basel). 2022;12(5):1141. Go to original source... Go to PubMed...
  19. Carter JD, Espinoza LR, Inman RD et al. Combination antibiotics as a treatment for chronic Chlamydia‑induced reactive arthritis: a double‑blind, placebo‑controlled, prospective trial. Arthritis Rheum. 2010;62(5):1298-307. Go to original source... Go to PubMed...
  20. Barber CE, Kim J, Inman RD et al. Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis. J Rheumatol. 2013;40(6):916-928. Go to original source... Go to PubMed...
  21. Zeidler H, Hudson AP. Quo vadis reactive arthritis? Curr Opin Rheumatol. 2022;34(4): 218-224. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.